Phase 3 randomised study of avatrombopag, a novel thrombopoietin receptor agonist for the treatment of chronic immune thrombocytopenia.
Jurczak, Wojciech *,1; Chojnowski, Krzysztof 2; Mayer, Jiri 3; Krawczyk, Katarzyna 1; Jamieson, Brian D. 4; Tian, Wei 4; Allen, Lee F. 4
[Miscellaneous Article] British Journal of Haematology. 183(3):479-490, November 2018.

(Format: HTML, PDF)